Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles
Open Access
- 13 October 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 146 (3) , 371-380
Abstract
A single infusion of pamidronate was given to patients with systemic sclerosis (scleroderma, SSc) to assess effects on cytokine production by peripheral blood mononuclear cells (PBMC) and lymphocyte subsets. Eighteen patients with SSc received a single intravenous dose of 60 mg of pamidronate and were followed for 6 months. Assessment of cytokine production [interferon (IFN)-γ, interleukin (IL)-10, transforming growth factor (TGF)-β1, tumour necrosis factor (TNF)-α and IL-4] by PBMC and lymphocyte subsets by flow cytometry was carried out before and after the pamidronate infusion. Unstimulated PBMC produced increased amounts of IFN-γ and TNF-α and reduced levels of TGF-β1 for up to 24 weeks after the infusion. γδ T cells from patients with SSc were activated in vitro and produced increased IFN-γ. The effects of pamidronate on modulation of cytokine profiles in patients with SSc may merit future study.Keywords
This publication has 56 references indexed in Scilit:
- Alendronate reduces serum TNF? and IL-1?, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosisJournal of Bone and Mineral Metabolism, 2004
- Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of boneBone, 2004
- Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane‐associated tumor necrosis factor αArthritis & Rheumatism, 2003
- Human γ/δ T-cell proliferation and IFN-γ production induced by hexamethylene diisocyanateJournal of Allergy and Clinical Immunology, 2003
- γδ T cells for immune therapy of patients with lymphoid malignanciesBlood, 2003
- Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurrent Opinion in Rheumatology, 2001
- Influence of Alternatively and Classically Activated Macrophages on Fibrogenic Activities of Human FibroblastsCellular Immunology, 2000
- Evidence for Exclusive Role of the p55 Tumor Necrosis Factor (TNF) Receptor in Mediating the TNF-Induced Collagenase Expression by Human Dermal FibroblastsJournal of Investigative Dermatology, 1996
- Interleukin‐1, Interleukin‐2, Interleukin‐4, Interleukin‐6, Tumor Necrosis Factor α, and Interferon‐γ Levels in Sera from Patients With SclerodermaArthritis & Rheumatism, 1992
- A Possible Role for Transforming Growth Factor-β in Systemic SclerosisJournal of Investigative Dermatology, 1990